Table 2 Baseline CMR characteristics according to patient cohort (Total N = 110)
Characteristic | MetS-MI- (n = 16) | MetS + MI- (n = 32) | MetS-MI + (n = 30) | MetS + MI + (n = 32) |
|---|---|---|---|---|
LV EDV (indexed to BSA) | 78.9 (59.4–98.4) | 80.2 (66.8–93.6) | 99.8 (87.3–112.3)* | 113.0 (98.3–127.6)* |
LV EF (%) | 63 (54 – 72) | 58 (50 – 66) | 40 (33 – 47)* | 34 (29 – 40)* |
LV mass (indexed to BSA) | 71.2 (56.6-85.9) | 74.1 (65.6-82.7) | 82.6 (75.2-89.9) * | 90.2 (81.8-98.6) * |
Injury pattern on LGE CMR | 0 | 0 | 30 (100%) | 32 (100%) |
−1 vascular territory | NA | NA | 24 (80%) | 18 (56.3%) |
- ≥ 2 vascular territories | NA | NA | 6 (20%) | 14 (43.8%) |
Total scar (% LV Mass) | 2.1 ± 2.1 | 3.6 ± 7.5 | 21.1 ± 14.7* | 21.0 ± 15.4* |
Non-indexed ITFV (ml) | 191 ± 125 | 506 ± 269* | 500 ± 293* | 668 ± 292* |
Indexed ITFV (ml/kg/m2) | 22.3 ± 10.6 | 28.6 ± 12.6* | 30.6 ± 12.3* | 35.2 ± 11.4* |